Scaling of Cmin [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2014-12-11 15:53 (3421 d 01:37 ago) – Posting: # 14056
Views: 13,147

Dear Detlew,

❝ ❝ ... I’m working on it. EMA’s preference of an all-fixed model is nasty. My current setup is: Sequence+Subject(Sequence)+Treatment+Replicate+Treatment(Replicate)+Period


❝ That's weird. Two times Treatment in the model :confused:.


Dammit! I’m not sure how to reproduce Liu’s results anyhow. :confused: Work in progress.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,992 posts in 4,827 threads, 1,649 registered users;
69 visitors (1 registered, 68 guests [including 8 identified bots]).
Forum time: 18:31 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5